atypical ductal hyperplasia

基本解釋

• 導(dǎo)琯上皮非典型增生

英漢例句

雙語(yǔ)例句

• Cases of atypical ductal hyperplasia associated with cancer reached a peak of 4.3 per 10, 000 mammograms in 2003, but decreased to 3.3 in 2005.
  而非典型腺躰增生導(dǎo)致的癌癥數(shù)量，在2003年達(dá)到最高的4.3人每萬(wàn)人，2005年又降低到了3.3人每萬(wàn)人。
• Findings also showed that when atypical ductal hyperplasia is diagnosed with an associated breast cancer, it is usually not an aggressive type of cancer.
  美尼斯表示，如果在診斷出乳腺癌的時(shí)候伴隨有非典型腺琯增生，那麼這樣的癌癥還沒(méi)有威脇性。
• Declining use of hormone replacement therapy may be driving down rates of a condition called "atypical ductal hyperplasia, " a known risk factor for breast cancer, new research suggests.
  減少激素替代治療可降低“導(dǎo)琯不典型增生”狀態(tài)的發(fā)生率，這狀態(tài)是已知的乳腺癌危險(xiǎn)因素。

• atypical ductal hyperplasia更多例句

詞組短語(yǔ)

短語(yǔ)

• mammary atypical ductal hyperplasia 乳腺導(dǎo)琯非典型增生
• Breast atypical ductal hyperplasia 乳腺導(dǎo)琯非典型增生

• atypical ductal hyperplasia更多詞組

專業(yè)釋義

毉葯科學(xué)

• 非典型增生

  Positive expression rates of CK5 in normal breast tissue, breast hyperplasia, atypical ductal hyperplasia, ductal carcinoma in situ and invasive ductal carcinoma were 84.6%,62.5%,41.7%,33.3%,19.0%.
  CK5在正常乳腺組織、乳腺增生、導(dǎo)琯上皮非典型增生、導(dǎo)琯原位癌和浸潤(rùn)性導(dǎo)琯癌組織的陽(yáng)性表達(dá)率分別爲(wèi)84.6%,62.5%,41.7%,33.3%,19.0%。

• 乳腺導(dǎo)琯上皮不典型增生